BioCentury | Sep 1, 2020
Product Development

Aug. 31 Quick Takes: Mylan, Biocon launch cheaper insulin in U.S.; plus: AZ, bluebird, Lipocine, Amgen, AbbVie-Morphic, Polyphor-Fosun and Milestone

...10% to $1.48 Monday.Amgen joins Dow Jones Amgen Inc. (NASDAQ:AMGN) became the first biotech to join the Dow Jones...
BioCentury | Jul 10, 2020
Finance

With record fund flows, biotech a top sector for investors heading into 3Q20

...climbed 31%, and the S&P Biotech ETF (XBI) rose over 45% . In contrast, the Dow Jones...
BioCentury | Jun 12, 2020
Finance

June 11 Quick Takes: Biotech swept up in sell-off; plus Simcere, Lantern, Cue Health, C2i, BaseLaunch, Sanofi-Cathay and 4BIO

...sparked by fears of an increase in COVID-19 infections. The NASDAQ Composite, S&P 500 and Dow Jones...
BioCentury | May 8, 2020
Finance

Follow-on market poised for comeback, at least temporarily

...reaction was swift and severe. In the span of one month, the S&P 500 and Dow Jones...
BioCentury | May 1, 2020
Finance

As market’s upbeat April draws to close, Lyra becomes latest biotech IPO to surge

...emerged. The XBI finished the month down about 4% from mid-February levels. During April, the Dow Jones...
BioCentury | Mar 13, 2020
Finance

Cratering market spoils Imara’s NASDAQ debut

...falling $2.07 (11%) to $16.79 (see “Biotechs Cede Ground to End Wild Week” ) The Dow Jones...
BioCentury | Mar 12, 2020
Product Development

COVID-19 Update: Biden blasts testing shortfall; Biogen to manufacture Vir’s mAbs; Gates funding Inovio’s device; Cruz wants reciprocal approvals

...rights in Greater China. Vir gained $3.83 (11%) to $37.60 on a day when the Dow Jones...
BioCentury | Mar 10, 2020
Finance

Diagnostics companies survive Monday’s market rout

...to continued fears over the COVID-19 outbreak and a steep drop in oil prices. The Dow Jones...
BioCentury | Feb 29, 2020
Finance

Retail investors provide week’s only bright spots for biotech amid downturn

...of steep declines Friday but they still ended the week in correction territory, with the Dow Jones...
BioCentury | Feb 28, 2020
Finance

COVID-19 fears continue to roil markets

...stoked investor fears, with the broader markets tumbling again and dragging biopharma with it. The Dow Jones...
Items per page:
1 - 10 of 331
BioCentury | Sep 1, 2020
Product Development

Aug. 31 Quick Takes: Mylan, Biocon launch cheaper insulin in U.S.; plus: AZ, bluebird, Lipocine, Amgen, AbbVie-Morphic, Polyphor-Fosun and Milestone

...10% to $1.48 Monday.Amgen joins Dow Jones Amgen Inc. (NASDAQ:AMGN) became the first biotech to join the Dow Jones...
BioCentury | Jul 10, 2020
Finance

With record fund flows, biotech a top sector for investors heading into 3Q20

...climbed 31%, and the S&P Biotech ETF (XBI) rose over 45% . In contrast, the Dow Jones...
BioCentury | Jun 12, 2020
Finance

June 11 Quick Takes: Biotech swept up in sell-off; plus Simcere, Lantern, Cue Health, C2i, BaseLaunch, Sanofi-Cathay and 4BIO

...sparked by fears of an increase in COVID-19 infections. The NASDAQ Composite, S&P 500 and Dow Jones...
BioCentury | May 8, 2020
Finance

Follow-on market poised for comeback, at least temporarily

...reaction was swift and severe. In the span of one month, the S&P 500 and Dow Jones...
BioCentury | May 1, 2020
Finance

As market’s upbeat April draws to close, Lyra becomes latest biotech IPO to surge

...emerged. The XBI finished the month down about 4% from mid-February levels. During April, the Dow Jones...
BioCentury | Mar 13, 2020
Finance

Cratering market spoils Imara’s NASDAQ debut

...falling $2.07 (11%) to $16.79 (see “Biotechs Cede Ground to End Wild Week” ) The Dow Jones...
BioCentury | Mar 12, 2020
Product Development

COVID-19 Update: Biden blasts testing shortfall; Biogen to manufacture Vir’s mAbs; Gates funding Inovio’s device; Cruz wants reciprocal approvals

...rights in Greater China. Vir gained $3.83 (11%) to $37.60 on a day when the Dow Jones...
BioCentury | Mar 10, 2020
Finance

Diagnostics companies survive Monday’s market rout

...to continued fears over the COVID-19 outbreak and a steep drop in oil prices. The Dow Jones...
BioCentury | Feb 29, 2020
Finance

Retail investors provide week’s only bright spots for biotech amid downturn

...of steep declines Friday but they still ended the week in correction territory, with the Dow Jones...
BioCentury | Feb 28, 2020
Finance

COVID-19 fears continue to roil markets

...stoked investor fears, with the broader markets tumbling again and dragging biopharma with it. The Dow Jones...
Items per page:
1 - 10 of 331